343 related articles for article (PubMed ID: 26643655)
1. Novel approaches to treating Clostridium difficile-associated colitis.
Padua D; Pothoulakis C
Expert Rev Gastroenterol Hepatol; 2016; 10(2):193-204. PubMed ID: 26643655
[TBL] [Abstract][Full Text] [Related]
2. Is fecal microbiota transplantation a temporary patch for treatment of Clostridium difficile infection or a new frontier of therapeutics?
Khoruts A
Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):435-438. PubMed ID: 29667436
[No Abstract] [Full Text] [Related]
3. Treatment of Clostridium difficile infection in pediatric patients.
Esposito S; Umbrello G; Castellazzi L; Principi N
Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):747-55. PubMed ID: 25912469
[TBL] [Abstract][Full Text] [Related]
4. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
5. [Clostridium Difficile: Monoclonal Antibody Therapy and Vaccines].
Reisinger EC; Ebbers M; Löbermann M
Dtsch Med Wochenschr; 2019 Jun; 144(12):842-849. PubMed ID: 31212328
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile colitis: A clinical review.
Ong GK; Reidy TJ; Huk MD; Lane FR
Am J Surg; 2017 Mar; 213(3):565-571. PubMed ID: 28131326
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplant for C. difficile infection: Just say yes.
Cammarota G; Gallo A; Bibbò S
Anaerobe; 2019 Dec; 60():102109. PubMed ID: 31644957
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile Colitis Prevention and Treatment.
Dinleyici M; Vandenplas Y
Adv Exp Med Biol; 2019; 1125():139-146. PubMed ID: 30689174
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile infection: Updates in management.
Tariq R; Khanna S
Indian J Gastroenterol; 2017 Jan; 36(1):3-10. PubMed ID: 27995486
[TBL] [Abstract][Full Text] [Related]
10. Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity.
Carlucci C; Petrof EO; Allen-Vercoe E
EBioMedicine; 2016 Nov; 13():37-45. PubMed ID: 27720396
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile colitis: pathogenesis and host defence.
Abt MC; McKenney PT; Pamer EG
Nat Rev Microbiol; 2016 Oct; 14(10):609-20. PubMed ID: 27573580
[TBL] [Abstract][Full Text] [Related]
12. Novel therapies for severe Clostridium difficile colitis.
Waltz P; Zuckerbraun B
Curr Opin Crit Care; 2016 Apr; 22(2):167-73. PubMed ID: 26771898
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Clostridium difficile infection: a national survey of clinician recommendations and the use of faecal microbiota transplantation.
Prior AR; Kevans D; McDowell L; Cudmore S; Fitzpatrick F
J Hosp Infect; 2017 Apr; 95(4):438-441. PubMed ID: 28029471
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile, the Difficult "Kloster" Fuelled by Antibiotics.
Dicks LMT; Mikkelsen LS; Brandsborg E; Marcotte H
Curr Microbiol; 2019 Jun; 76(6):774-782. PubMed ID: 30084095
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia.
Merlo G; Graves N; Brain D; Connelly LB
J Gastroenterol Hepatol; 2016 Dec; 31(12):1927-1932. PubMed ID: 27043242
[TBL] [Abstract][Full Text] [Related]
16. Exploring ways to improve CDI outcomes.
Galpérine T; Guery B;
Med Mal Infect; 2018 Feb; 48(1):10-17. PubMed ID: 29336930
[TBL] [Abstract][Full Text] [Related]
17. [Current treatment and epidemiology of Clostridium difficile infections].
Dinh A; Bouchand F; Le Monnier A
Rev Med Interne; 2015 Sep; 36(9):596-602. PubMed ID: 25772664
[TBL] [Abstract][Full Text] [Related]
18. Microbiome as mediator: Do systemic infections start in the gut?
Latorre M; Krishnareddy S; Freedberg DE
World J Gastroenterol; 2015 Oct; 21(37):10487-92. PubMed ID: 26457009
[TBL] [Abstract][Full Text] [Related]
19. Hyperimmune bovine colostrum as a novel therapy to combat Clostridium difficile infection.
Sponseller JK; Steele JA; Schmidt DJ; Kim HB; Beamer G; Sun X; Tzipori S
J Infect Dis; 2015 Apr; 211(8):1334-41. PubMed ID: 25381448
[TBL] [Abstract][Full Text] [Related]
20. New drugs and strategies for management of Clostridium difficile colitis.
Higa JT; Kelly CP
J Intensive Care Med; 2014; 29(4):190-9. PubMed ID: 23753229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
